DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
Frazier Life Sciences Management, L.P. 370,000$4,706,4000.31%
Nebula Research & Development LLC 33,169$421,9100.22%
GSA CAPITAL PARTNERS LLP 162,699$2,0700.18%
Virtus ETF Advisers LLC 21,460$272,9710.17%
Polar Capital Holdings Plc 1,750,000$22,260,0000.16%
Leucadia National 738,743$9,396,8110.08%
FOX RUN MANAGEMENT, L.L.C. 22,540$286,7090.08%
Edmonds Duncan Registered Investment Advisors, LLC 17,747$225,7420.06%
DARK FOREST CAPITAL MANAGEMENT LP 60,216$765,9480.06%
PDT Partners, LLC 35,502$451,5850.06%
External links

This page lists DECIPHERA PHARMACEUTICALS IN's shareholders in Q3 2023. To view DECIPHERA PHARMACEUTICALS IN's shareholder history, click here.